{"product_id":"global-cancer-gene-therapy-market-growth-status-and-outlook-2023-2029","title":"Global Cancer Gene Therapy Market Growth (Status and Outlook) 2023-2029","description":"\u003cp\u003eGlobal Cancer Gene Therapy Market Growth (Status and Outlook) 2023-2029\u003c\/p\u003e\n\n\u003cp\u003eCancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has been discovered that the immune system could be manipulated to influence cancerous cells to destroy itself.\u003c\/p\u003e\n\n\u003cp\u003eLPI (LP Information)' newest research report, the “Cancer Gene Therapy Industry Forecast” looks at past sales and reviews total world Cancer Gene Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Cancer Gene Therapy sales for 2023 through 2029. With Cancer Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cancer Gene Therapy industry.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report provides a comprehensive analysis of the global Cancer Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M\u0026amp;A activity. This report also analyzes the strategies of leading global companies with a focus on Cancer Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cancer Gene Therapy market.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cancer Gene Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cancer Gene Therapy.\u003c\/p\u003e\n\n\u003cp\u003eThe global Cancer Gene Therapy market size is projected to grow from US$ 510.7 million in 2022 to US$ 1674.2 million in 2029; it is expected to grow at a CAGR of 18.5% from 2023 to 2029.\u003c\/p\u003e\n\n\u003cp\u003eSeveral unmet medical needs for treatment of cancer have encouraged R\u0026amp;D of cancer gene therapy. Various factors, such as increasing prevalence of cancer, rising government initiatives, increasing funding from various government and non-government organizations, are driving the global cancer gene therapy market. In addition, ethical acceptance of gene therapy for treatment of diseases and growing popularity of DNA vaccines is driving the global cancer gene therapy market. However, less awareness and high cost involved in treatment are restraining the growth of global market for cancer gene therapy.\u003c\/p\u003e\n\n\u003cp\u003eThis report presents a comprehensive overview, market shares, and growth opportunities of Cancer Gene Therapy market by product type, application, key players and key regions and countries.\u003c\/p\u003e\n\n\u003cp\u003eMarket Segmentation:\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by type\u003cbr\u003e\nOncolytic Virotherapy\u003cbr\u003e\nGene Transfer\u003cbr\u003e\nGene-Induced Immunotherapy\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by application\u003cbr\u003e\nHospitals\u003cbr\u003e\nDiagnostics Centers\u003cbr\u003e\nResearch Institutes\u003c\/p\u003e\n\n\u003cp\u003eThis report also splits the market by region:\u003cbr\u003e\nAmericas\u003cbr\u003e\nUnited States\u003cbr\u003e\nCanada\u003cbr\u003e\nMexico\u003cbr\u003e\nBrazil\u003cbr\u003e\nAPAC\u003cbr\u003e\nChina\u003cbr\u003e\nJapan\u003cbr\u003e\nKorea\u003cbr\u003e\nSoutheast Asia\u003cbr\u003e\nIndia\u003cbr\u003e\nAustralia\u003cbr\u003e\nEurope\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nUK\u003cbr\u003e\nItaly\u003cbr\u003e\nRussia\u003cbr\u003e\nMiddle East \u0026amp; Africa\u003cbr\u003e\nEgypt\u003cbr\u003e\nSouth Africa\u003cbr\u003e\nIsrael\u003cbr\u003e\nTurkey\u003cbr\u003e\nGCC Countries\u003c\/p\u003e\n\n\u003cp\u003eThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.\u003cbr\u003e\nAdaptimmune\u003cbr\u003e\nBluebird bio\u003cbr\u003e\nCelgene\u003cbr\u003e\nShanghai Sunway Biotech\u003cbr\u003e\nShenzhen SiBiono GeneTech\u003cbr\u003e\nSynerGene Therapeutics\u003cbr\u003e\nAltor BioScience\u003cbr\u003e\nAmgen\u003cbr\u003e\nArgenx\u003cbr\u003e\nBioCancell\u003cbr\u003e\nGlaxoSmithKline\u003cbr\u003e\nMerck\u003cbr\u003e\nOncoGenex Pharmaceuticals\u003cbr\u003e\nTransgene\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The report will take approximately 2 business days to prepare and deliver.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"March, 2023 \/ 100 Pages \/ MCW16228408","offer_id":47646858314034,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-cancer-gene-therapy-market-growth-status-and-outlook-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}